$RNA News Article - Avidity Biosciences Reports Positive Data Demonstrating AOC 1044 Delivers Unprecedented Concentrations of PMO in Muscle Following a Single Dose in Healthy Volunteers from Phase 1/2 EXPLORE44(TM) Trial for Duchenne Muscular Dystrophy
https://marketwirenews.com/news-releases/avid...78722.html